Delivery Order SPE2DB20D6037-SPE2DB22FD0GL
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,073.48 contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML. The order has a period of performance through June 30, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,985.30, is for the delivery of 4563043017 - Isosulfan Blue 1% Vial 5ML, with a period of performance through December 5, 2023. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,654.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of TISSUEBLUE 0.025% syringes in 0.5mL quantities. This firm fixed-price delivery order, issued on September 26, 2025, with an ultimate completion date of October 20, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,556.52, is for the delivery of a pharmaceutical product, specifically VisionBlue 0.06% Syringe 0.5ML. The contract has a completion date of September 8, 2023 and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. holds a larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,382.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 19, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, covers the supply of VisionBlue 0.06% syringes in 0.5ml units. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of ISOSULFAN BLUE 1% VIAL 5ML medical supplies, with a ceiling value of $7,430.84 and a period of performance through April 16, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
- This is a firm fixed-price delivery order (SPE2DB24D9144|SPE2DB24FCMMD) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $11,605.50 and has an ultimate completion date of October 16, 2024. DMS Pharmaceutical Group Inc. specializes in providing a wide range of pharmaceutical products and medical supplies to the U.S. federal government, primarily serving the Department of Defense...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $14,776.00, is to provide pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. This delivery order is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a total...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,013.70 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 0.5 mL syringes containing 0.025% Tissue Blue solution. This order is issued against DMS Pharmaceutical's indefinite delivery contract SPE2DB valued at up to $4,999,999 through 2025, which enables DLA to procure a broad range of pharmaceutical products for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 1 gram vials of Protopam Chloride, a specialized pharmaceutical product, with a ceiling value of $1,559.52 and a completion date of April 7, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB22FD0GLDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,212.60, is for the delivery of PROVAYBLUE 50 MG/10 ML AMPULE 10ML, a pharmaceutical product, with an ultimate completion date of August 31, 2022. The contract is not set aside for any specific business type. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 8/30/22 |